Societe Generale’s Medtronic MDT Stock Holding History

Societe Generale’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$1.19M	Buy	+178,500	New	+$14.4M	0.01%	1187

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Societe Generale's MDT Position: Q2 2016 in Review

Societe Generale opened a new position in Medtronic (MDT) in Q2 2016: 58,042 shares worth $5.04M. The stake represents 0.04% of the portfolio and ranks #393 among its holdings.

1,262 funds tracked by Wall St. Rank hold MDT as of Q2 2016.

Societe Generale held 58,042 shares of Medtronic worth $5.04M as of Q2 2016.
Medtronic was a new Societe Generale position in Q2 2016.
Medtronic made up 0.04% of Societe Generale's portfolio in Q2 2016, its #393 holding.
1,262 funds tracked by Wall St. Rank held Medtronic as of Q2 2016.

Based on Societe Generale's 13F filing for Q2 2016, filed 2 Aug 2016.